Latest Proprietary Technology News

Queensland Brine Solutions has locked in a strategic 10-hectare site to develop its Queensland Brine Management Complex, aiming to transform waste brine from the coal seam gas industry into valuable green chemicals.

Audeara Limited has landed its maiden purchase order for hearing aid technology in China, marking a pivotal step in its global expansion with production and launch planned for the final quarter of 2025.

Vinyl Group Ltd reports a striking 190% revenue surge in FY25 and a record Q1 FY26, setting sights on its first EBITDA-positive quarter by mid-2026.

Jumbo Interactive has acquired UK-based Dream Car Giveaways for A$109.9 million, marking its entry into the fast-growing UK prize draw market and establishing a significant B2C presence internationally.

Aurora Labs has secured over A$900,000 in contracts with the Australian Defence Force, pushing forward its advanced propulsion systems and additive manufacturing capabilities. A strategic partnership with Sovereign Propulsion Systems aims to integrate these innovations into next-generation unmanned aerial systems.

Vulcan Energy has locked in a binding lithium hydroxide supply agreement with Glencore, completing the key offtake contracts needed to finance its Phase One Lionheart Project. This milestone positions Vulcan to advance construction and meet growing European EV battery demand.

Metallium’s U.S. subsidiary has signed a pivotal Memorandum of Understanding with Glencore, setting the stage for a major supply and offtake partnership in electronic scrap recycling. This collaboration underpins Metallium’s Texas facility launch and validates its proprietary technology in a competitive market.

Papyrus Australia has appointed Daniel Schmidt as CEO and secured a $250k government grant alongside a binding agreement to produce biodegradable mining products, marking a decisive shift from R&D to commercial operations.

Vection Technologies reports a 60% revenue surge in 1H25, secures a $21 million equity raise, and strengthens its position in defence AI and spatial computing with a robust $75 million sales pipeline.

Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.

Vection Technologies has landed a $22.3 million multi-year framework agreement with a NATO-approved European defence partner, boosting its defence program value to $40 million through 2030.

Everlast Minerals Ltd has issued a Replacement Prospectus for a $4-6 million ASX IPO to fund its mineral sands projects in Bangladesh, focusing on advancing the Gaibandha project towards commercial production.